Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.46, read 2026-10-23
Ethical does not pass the values gate
Price117.44 USD
Fair value120.00
Ethical score10.0/100
RatingAVOID
Our investment reviews on this name
2026-10-27Read Markup98.76+18.9% to today ✓Accumulation gives way to Markup after a 10% rise in 2 weeks
2026-10-11Read Accumulation89.45+31.3% to today ✓Markdown gives way to Accumulation
2026-08-31Read Markdown93.54+25.6% to today Distribution gives way to Markdown after an 11% rise in 9 weeks
2026-07-02Read Distribution84.18+39.5% to today First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Hasbro holds its Markup at $117.44. The statistical read favours the buyers, held for 2 days.
As held on the ledger · 2026-10-23
Phase
Markup
Quantitative state
The statistical read favours the buyers, held for 2 days
Price at the screen
$117.44
Valuation
17.67 trailing · 15.19 forward price to earnings
Values screen
FAIL· score 10.0
Beta
0.44
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
59.36%
Below 33%
Interest-bearing debt is 59.4% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
1.90%
Below 33%
Cash held in interest-bearing accounts and securities is 1.9% of assets, under the one-third limit.
Pass
Receivables
33.07%
Below 49%
Money owed to the company is 33.1% of assets, under the 49% limit.
Pass
Revenue purity
0.61%
Below 5%
Only 0.6% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Hasbro's business is in a permissible area, but its interest-bearing debt is about 59% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when HAS's ethical verdict changes
Today HAS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Conscience Overlay
Conscience flag · Consumer boycott campaigns
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Cited in consumer boycott campaigns for corporate ties and product distribution in Israel. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads AVOID: it trades at roughly a 22% discount to our $120.00 fair value, weak competitive moat, 16.20% revenue growth.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 21.5% margin of safety to the base estimate.
Third-party analyst targets: 13 covering, consensus Strong Buy. The average target sits −3% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Toy Giant's Debt Breaks Every Ethical Rule
Every time a child rips open a new board game or trading card pack, Hasbro should be printing cash. Instead the company is posting a negative five percent profit margin and a negative twenty three percent return on equity while its debt ratio has already tripped our ethical screen.
We pass for clear reasons. The business carries weak competitive protection, revenue growth of thirteen percent has not translated into profits, and the forward multiple of twelve point eight times sits on top of losses rather than earnings power. Analyst enthusiasm and a hundred and ten dollar median target do not override the balance sheet reality.
The real risk is a classic cyclical trap where peak toy demand meets stretched leverage. Any slowdown in consumer spending would quickly expose how little room exists for error. Analysis, not advice.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
HAS trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-27Markup · changed$98.76+0.0%Entry 16
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $113.
2026-10-20Accumulation$98.76+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $113. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Accumulation$98.76+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $113. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Accumulation$98.76+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $113. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Accumulation$98.76+2.9%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $113. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Accumulation$95.94+2.8%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $113. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Accumulation$93.32+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $113. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Accumulation$93.32+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $113. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-13Accumulation$93.32+4.3%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $113. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $113.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
